About us

Dianosic designs transformative intranasal solutions changing physicians experience and supporting a rapid return of patients to daily life activities.

Our history

2024

Dianosic pursue its preclinical plan as planned and confirms its good initial results for the ARIS-R program.
An increasing number of clinical centers join the CAVI-T observational study. 
First formulation studies in Central Nervous System (CNS) therapeutic areas (Schizophrenia, Parkinson) have been initiated.

2023

Dianosic raises €4.7M to prepare for clinical trial in chronic rhinitis.
Launch of the new CAVI-T balloon with anti-migration feature.
Promising ARIS-R preclinical in vivo results.
Dianosic adds Central Nervous System as a new vertical and strengthens its ARIS platform.

2022

Dianosic ranks in the top 10 of European Medtech startups.
Design of a fully functional prototype of the ARIS solution for chronic allergic rhinitis (ARIS-R)

2021

Dianosic receives the SNITEM’s ‘public’s favorite’ award.
Successful European launch of CAVI-T post COVID pandemic.
Launch of digital training tools for CAVI-T.

2020

Dianosic closes a first round of financing of 1.5M euros.
Publication of the first clinical results for CAVI-T.
CE marking of CAVI-T and ISO 13485 certification.

2019

Dianosic becomes laureate of the prestigious I-Lab 2019 innovation contest.

2018

Dianosic relocates to the city of Strasbourg.

2017

Development of the CAVI-T asymmetric intranasal balloon, a minimally-invasive solution to improve the treatment of epistaxis.
The Active Resorbable Intranasal Scaffold (ARIS) development program starts in rhinitis and sinusitis.

Origin

Marc Augustin (Chairman), Philippe Bastide (CEO), and Pr. Christian Debry (ENT surgeon) create Dianosic in Paris to tackle unmet needs in otorhinolaryngology (ENT) / Respiratory diseases, including chronic allergic rhinitis, chronic rhinosinusitis and epistaxis.

Our mission and ambitions

Dianosic's Commitment to Enhancing respiratory care

Ear Nose and Throat (ENT) conditions are the leading cause of physicians’ visits. There is significant room for improvement to address unmet clinical needs. Dianosic collaborates with healthcare professionals in order to provide advanced ENT solutions that will change patients’ lives in chronic rhinitis, chronic rhinosinusitis and intranasal bleeding (epistaxis). The company strives for:

Maximize patients quality of life, supporting a rapid return to daily life activities.

Optimize efficacy and safety through low dose, targeted drug delivery.

Leverage our intranasal drug delivery platform to treat central nervous system diseases.

Reduce hospitalization time and frequency.

Transformative intranasal solutions Transformative intranasal solutions

Dianosic's future : A paradigm shift with transformative innovations

Discover our programs: ARIS-R, ARIS-S and more

Dianosic develops a platform of Active Resorbable Intranasal Scaffolds (ARIS) aiming at delivering a targeted, reduced dose of drug to the nasal cavity with an “insert and forget” solution. ARIS provides a long term, sustained-release treatment revolutionizing the management of chronic diseases such as rhinitis and rhinosinusitis The innovative technology of the ARIS platform is highly scalable and promising in the field of Central Nervous System, leveraging the Nose-To-Brain concept in schizophrenia, Parkinson, etc.

Our team

Qualified team with complementary profiles

Marc Augustin Chairman / Founder

Seasoned entrepreneur
>20 years of experience in Finance and International Development (Stellantis, IBM)
Member of the executive committee of the health insurancel company UNEO
Merger Acquisition / fundraising advisor (ACM partners)
Linkedin account: https://bit.ly/3EvE9u1

Philippe Bastide CEO/ Founder

> 20 years of experience in Medtech and Pharma (Pfizer, Johnson & Johnson, Livanova)
Business Unit Lead at Acclarent (ENT Division of Johnson & Johnson)
Expertise in Market Access (pricing & reimbursement), Business Development and Professional Education
Linkedin account: https://bit.ly/3sRamJv

Emilie Fournier CSO - Chief Scientific Officer

10 years' experience in medical devices and pharmaceuticals (Roche)
Expertise in quality management & regulatory affairs
Doctorate in Biology from the University of Strasbourg (CIFRE SANOFI)
Linkedin account: https://bit.ly/44RT6l2

Eric Le Goff CMC Director

14 years of experience in pharmaceutical development, generics, orphan drugs and combination products
CMC Regulatory Project Management invariuous companies (INNOTHERA, NOVARTIS, OT4B )
Expertise in product development and analytical chemistry
Linkedin account: https://bit.ly/44GfrSh

Khadija Elhabazi QA & RA

Quality, Regulatory and Clinical Operations Engineer
10 years' experience in research projects (University of Strasbourg)
Expertise in in vivo studies
PhD in Pharmacology + Diploma in Clinical Research
Linkedin account: https://bit.ly/3sQRomk

Victor Moreau R&D Engineer

Healthcare engineer (Master's degree in healthcare engineering, medical devices option, Montpellier, DEDIENNE SANTÉ)
Expertise in medical device (or healthcare product) design
Specialized in biodegradable polymers and active ingredient release
Linkedin account: https://bit.ly/3LfIgOD

Pedro Costa Campos COO - Chief Operating Officer

Over 20 years' career in the healthcare industry
Solid experience in general management, operational strategy, business development, marketing and sales management at international level, across regions (Johnson & Johnson).
Linkedin account: https://bit.ly/3EvE9u1

Hamed Moghadam Business development

17 years' experience in medical devices and pharmaceuticals (Johnson & Johnson, Medtronic, Boston Scientific)
Regional Sales Manager Acclarent (Johnson & Johnson)
Expertise in Product Launch, Business development, Strategy
Linkedin account: https://bit.ly/3Zbn0PD

Romain Alberico Marketing & Sales Consultant

15+ years of experience in the field of Medtech and he held different Sales and Global Marketing positions at Boston Scientific, LivaNova and, more recently, SuperSonic Imagine
Strong appetite for innovative marketing and sales approaches
Linkedin account: https://bit.ly/464yWoW

Marie Lahaye Digital project Manager

Expertise in marketing and digital communication
Specialized in brand content and web content creation
Linkedin account: https://bit.ly/45Ge9YJ

Jean-Charles Vignole Sales

Student at ESSCA business school, Master international Business / Marketing
Professional experience in the Medtech world (Johnson & Johnson)
Linkedin account: https://bit.ly/3ZgllbS

Nathalie Stiegler Office Manager

More than 25 years' experience as an office manager
Expertise in organizational, HR and financial administration
Part-time Office Manager in several innovative start-ups in Strasbourg
Linkedin account: https://bit.ly/3Re5acP

Pr. Christian Debry ENT surgeon / Founder

ENT Surgeon, University Hospital of Strasbourg, France
Rhinology and skull base surgery expert
Co-Director of the INSERM 1121 Research Unit (“Bioengineering and biomaterial)
Co-Director of the lab for skull base surgery (IRCAD)
Board member of the French ENT Society, French College of ENT and Head & Neck Surgery and the French Association for Pediatric ENT
Founder of Protip Médical (World first implantation of an artificial larynx, 2012)
Linkedin account: https://bit.ly/3P8tcn5

Pr. Howard Levine ENT surgeon

ENT surgeon (USA)
Founding Director of the Cleveland Nasal-Sinus & Sleep Center
Past President of the American Rhinologic Society
Former Vice President of Medical Affairs at Acclarent (J&J)
Featured in the prestigious “Best Doctors in America” and “America’s Top Doctors” lists
Investigator, lecturer and co-author of ENT reference articles

Pr. Wytske Fokkens ENT surgeon

ENT surgeon at Amsterdam University Medical Centres
World renowned specialist in the field of sinus and skull base surgery
Member of the key international Scientific Societies (ERS, EPOS, ARIA, GA2LEN)
Author of more than 500 scientific articles

Pr. Sébastien Froelich Neurosurgeon

Neurosurgeon, Lariboisière Hospital, APHP (Paris)
Neurosurgeon, Lariboisière Hospital, APHP (Paris)
President of the « Skull base » Committee of the Worldwide Federation of Neurosurgery (WFNS)
Executive member of the European Skull Base Society (ESBS)

Dr. Zara Patel Associate ENT Surgeon

Director of Endoscopic Skull Base Surgery (Stanford School of Medicine)
Associate Professor of Otolaryngology – Head and Neck Surgery (Stanford School of Medicine)
Expert in advanced endoscopic sinus and skull base surgery
Member of the Board of Directors (American Rhinologic Society)
Author of ENT reference articles

Pr. Claire Hopkins ENT surgeon

Consultant ENT Surgeon at Guy’s and St Thomas’ Hospital (London)
World renowned specialist focusing on rhinology and anterior skull base surgery
Chair of the UK Rhinosinusitis Commissioning Guidance Group and the Treasurer for the European Rhinologic Society
Claire has published over 150 papers in medical journals and 20 book chapters

Pr. André Coste ENT surgeon

ENT surgeon (CHI Créteil, France)
Specialized in rhinology and skull base surgery
Reviewer in key ENT Journals (B-ENT, Am J Rhinol, Rhinology, Eur Ann of Otolaryngology, Intensive Care Medicine)
Permanent member of the French Rhinology Association (AFR)
Pr. Coste does not receive any financial compensation for his work as scientific advisor

Pr. Olivier Malard ENT surgeon

ENT surgeon (University hospital of Nantes, France)
Expert in rhinology, head and neck surgery
Member of Inserm Research Unit 1229 (Regenerative Medicine and Skeleton (RMeS))
Member of the French Society of Rhinology and Head and Neck Oncology
Pr. Malard does not receive any financial compensation for his work as scientific advisor

Pr. Pablo Stolovitzky ENT Surgeon

Adjunct Associate Professor, Dept. of Otolaryngology, Emory University
CEO, ENT of Georgia North
General Secretary, Pan-American ORL Association
Past Director, AAO-HNS Board of Directors
International Steering Committee, AAO-HNS
President of the 2022 Pan-American Congress of Otolaryngology
Investigator and author of Otolaryngology reference articles

Pr. Eric Vicaut Health Technology Assessment expert

HTA expert, Statistician and clinical trials methodologist (Paris, Fernand Widal, APHP)
Former member of Marketing Authorization Commission and Medical Devices Commission (CNEDIMTS)
Founder of the Medical Devices Evaluation Center (CEDM)
Member of the Galien Awards jury
Pr. Vicaut does not receive any financial compensation for his work as scientific advisor

Sandra Spiritelli

International business executive, 25+ years experience in MedTech Strategy, M&A, BD, Marketing and HR
Cross-functional expertise in Medtech innovation and R&D ventures: R&D, QA, RA, CA, IP, Market Access, Therapy Development, Marketing
PMO expertise for cross border divestitures and corporate change management programs

Michel Ginestet

Leadership roles at Pfizer: Director of the Global Innovative Products Business Unit, President of Pfizer France, and Director of the Primary Care Business Unit
> 30 years’ experience in strategy, sales, market access, business development in the pharmaceutical industry, and health policy
Board member of LEEM (Les Entreprises du Médicament)

Catherine Picard

Vice President, Advanced Innovation and Strategic Investments (Cochlear)
Senior Executive Leader in the Healthcare MedTech sector, with a passion for Innovation, R&D Management, Strategy, Organization design and Change management

Guillaume Vetter-Genoud

Director - Quest For Health, Startup accelerator in the Grand East Region
> 20 years’ experience in international, interdisciplinary contexts specializing in biotech and Medtech, including leadership, mentoring, and board membership for startups

Lilla Mérabet

Vice President for Competitiveness, Innovation, and Digital Affairs in the Grand Est region
Senior Advisor/Independent Director of companies

Paul de Mestier

Managing Director - Healthcare Investment Banking (Bryan, Garnier & Co)

Our partners

We built a solid network of partners to support company funding and growth.

We are backed by Business Angels, a leading crowdfunding platform (Wiseed), the Fondation force, BPI, Banque Populaire and Caisse d’Epargne Grand Est. Since inception, the support of Region Grand Est, Quest for Health, Biovalley France, Conectus and the Eurometropole has been of paramount importance.

To learn more about our current projects, long-term strategy and partners, please visit our “News & partners” page. Join us and be part of the Dianosic adventure.